Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (39)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pfau, W.
Right arrow Articles by Wiessler, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pfau, W.
Right arrow Articles by Wiessler, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1990 Oxford University Press

research-article

32P-Postlabelling analysis of the DNA adducts formed by aristolochic acid I and II

Wolfgang Pfau 1, Heinz H. Schmeiser and Manfred Wiessler

Institute of Toxicology and Chemotherapy, German Cancer Research Center Im Neuenheimer Feld 280, D-6900 Heidelberg, FRG

We report the quantitation of DNA adducts in target and non-target organs of male Wistar rats treated orally with five daily doses (10 mg/kg body wt) aristolochic acid I (AAI) or aristolochic acid II (AAII), the major components of the herbal drug aristolochic acid, a forestomach carcinogen In the rat. DNA adducts were detected and analysed using the nuclease P1-enhanced variation of the Randerath 32 postlabeiling assay. The highest level of DNA adducts formed was by AAI inthe target organ, forestomach (330 ± 30 adducts/108 nucleotides), but high levels were also observed in a non-target tissue, the glandular stomach (180 ± 15). Lower amounts of adducts were detected in liver, kidney and urinary bladder epltheliuin. With AAII the binding Levels were generally lower than the AAII, the highest Level of adducts being detected in kidney (80 ± 20 adducts/108 nucleotides) and lower levels in liver, stomach and urinary bladder epithelia. Adduct patterns similar to those in vivo were observed in two new in vitro assays. Rat faecal bacteria were shown to be able to activate AM and AAII to reactive species, which were trapped with exogenous calf thymus DNA and analysed by postlabelling. llncuhatlon of AM and AAII in explanted rat stomach held in short-term organ culture resulted In DNA adduct formation in the epithelia of both forestomach and glandular stomach. To assign the recently characterized in vitro nucleoside adducts of AII to the bisphosphate derivatives, a new ion-pair H]PLC procedure on a reversed-phase column was developed. By monitoring Cerenkov radiation on-line, a good separation of AII adducts was observed, demonstrating that adducts formed in vivo were chromatographically indistinguishable with those formed in vitro, and previously characterized as an aristolactam moiety bound covalently to the exocydlic amino groups of deoxyadenosine and deoxyguanosine.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
S. Attaluri, R. R. Bonala, I.-Y. Yang, M. A. Lukin, Y. Wen, A. P. Grollman, M. Moriya, C. R. Iden, and F. Johnson
DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells
Nucleic Acids Res., October 23, 2009; (2009) gkp815v1.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. Shibutani, H. Dong, N. Suzuki, S. Ueda, F. Miller, and A. P. Grollman
Selective Toxicity of Aristolochic Acids I and II
Drug Metab. Dispos., July 1, 2007; 35(7): 1217 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
W. Chan, H.-B. Luo, Y. Zheng, Y.-K. Cheng, and Z. Cai
Investigation of the Metabolism and Reductive Activation of Carcinogenic Aristolochic Acids in Rats
Drug Metab. Dispos., June 1, 2007; 35(6): 866 - 874.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H. Dong, N. Suzuki, M. C. Torres, R. R. Bonala, F. Johnson, A. P. Grollman, and S. Shibutani
QUANTITATIVE DETERMINATION OF ARISTOLOCHIC ACID-DERIVED DNA ADDUCTS IN RATS USING 32P-POSTLABELING/POLYACRYLAMIDE GEL ELECTROPHORESIS ANALYSIS
Drug Metab. Dispos., July 1, 2006; 34(7): 1122 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Stiborova, E. Frei, B. Sopko, K. Sopkova, V. Markova, M. Lankova, T. Kumstyrova, M. Wiessler, and H. H. Schmeiser
Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase
Carcinogenesis, October 1, 2003; 24(10): 1695 - 1703.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
V. M. Arlt, M. Stiborova, and H. H. Schmeiser
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review
Mutagenesis, July 1, 2002; 17(4): 265 - 277.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Stiborova, E. Frei, B. Sopko, M. Wiessler, and H. H. Schmeiser
Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy
Carcinogenesis, April 1, 2002; 23(4): 617 - 625.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.